Libing Song
Impact in
- Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 1%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- Wnt/β-catenin signaling in development and cancer 14
- RNA modifications and cancer 14
- RNA Research and Splicing 11
- Epigenetics and DNA Methylation 11
-
- MicroRNA in disease regulation 21
- Cancer-related molecular mechanisms research 13
- Co-authors
- Jun Li (56 shared papers)Chuyong Lin (48 shared papers)Jueheng Wu (29 shared papers)Mengfeng Li (27 shared papers)Dong Ren (11 shared papers)Lili Jiang (11 shared papers)Jinrong Zhu (17 shared papers)Chunping Yu (8 shared papers)
- Journals
- Cancer Research (9 papers)Oncogene (8 papers)The Journal of Pathology (8 papers)PLoS ONE (7 papers)Oncotarget (7 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Libing Song
142 papers receiving 7.5k citations
Libing Song's Hit Papers
Peers
Comparison fields: 5 of 126
- Cancer Research 2.9k
- Molecular Biology 4.7k
- Oncology 1.4k
- Pathology and Forensic Medicine 722
- Cell Biology 634
Countries citing papers authored by Libing Song
This map shows the geographic impact of Libing Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libing Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libing Song more than expected).
Fields of papers citing papers by Libing Song
This network shows the impact of papers produced by Libing Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libing Song. The network helps show where Libing Song may publish in the future.
Co-authors
The 25 scholars most cited alongside Libing Song, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 147 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | HIF-1-Mediated Suppression of Acyl-CoA Dehydrogenases and Fatty Acid Oxidation Is Critical for Cancer Progression Hit paper breakdown → | 2014 | 290 |
| 2 | 2015 | 244 | |
| 3 | 2017 | 203 | |
| 4 | 2009 | 175 | |
| 5 | 2011 | 167 | |
| 6 | 2012 | 166 | |
| 7 | 2010 | 164 | |
| 8 | 2018 | 147 | |
| 9 | 2014 | 146 | |
| 10 | 2010 | 141 | |
| 11 | 2010 | 139 | |
| 12 | 2022 | 131 | |
| 13 | 2012 | 128 | |
| 14 | 2016 | 128 | |
| 15 | 2011 | 126 | |
| 16 | 2011 | 124 | |
| 17 | 2014 | 120 | |
| 18 | 2010 | 118 | |
| 19 | 2015 | 116 | |
| 20 | 2009 | 110 |
About Libing Song
Libing Song is a scholar working on Molecular Biology, Cancer Research, Oncology, Cell Biology and Pathology and Forensic Medicine, having authored 147 papers that have together received 7.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (21 papers), Wnt/β-catenin signaling in development and cancer (14 papers), RNA modifications and cancer (14 papers), Cancer Mechanisms and Therapy (13 papers), Cancer-related molecular mechanisms research (13 papers), RNA Research and Splicing (11 papers), Epigenetics and DNA Methylation (11 papers) and Cancer Cells and Metastasis (10 papers). The work is most often cited by research in Cancer Research (2.9k citations), Molecular Biology (4.7k citations), Oncology (1.4k citations), Pathology and Forensic Medicine (722 citations) and Cell Biology (634 citations). Libing Song has collaborated with scholars based in China, United States and France. Frequent co-authors include Jun Li, Chuyong Lin, Jueheng Wu, Mengfeng Li, Dong Ren, Lili Jiang, Jinrong Zhu, Chunping Yu, Xinsheng Peng and Geyan Wu. Their work appears in journals such as Cancer Research, Oncogene, The Journal of Pathology, PLoS ONE and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.